Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Industrial production method of esomeprazole

A technology of esomeprazole sodium and a production method is applied in the field of industrialized production of esomeprazole sodium, can solve problems such as large product loss, difficulty in stratification, inability to carry out industrialized production, etc., and achieves reduction in production energy consumption and The effect of raw material cost, saving production cost and environmental cost, high economic value and social benefit

Inactive Publication Date: 2015-04-08
合肥远志医药科技开发有限公司
View PDF9 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] CN102633776B and CN103601723A processes directly add excess sodium hydroxide solution to the reaction solution of step (2) asymmetric oxidation, which destroys the complex stable structure of tetraisopropyl titanate and D-ethyl tartrate, resulting in the oxidation of titanium The generation of fine particles is easy to form emulsification, which makes it difficult to stratify. CN102633776B and CN103288801A esomeprazole (compound represented by formula III) sulfoxide has poor stability, especially in an acidic atmosphere, it is very easy to oxidize and change color, and sulfoxide is oxidized to sulfone , while concentrating for a long time tends to cause the sulfone impurity (compound shown in formula IV) to become larger
CN103936715A The solvent of omeprazole thioether selects hydrophilic alcohols, reflux operation, and the reaction temperature is higher. At the same time, it needs precipitation to remove alcohols during post-treatment, and the energy consumption is higher. The esomeprazole potassium produced first in the follow-up steps , and then into crude sodium salt, refined, the steps are more cumbersome, and the product loss is greater
CN102746274A Esomeprazole (compound represented by formula III) is salted with trisodium phosphate, and then concentrated to dryness, which will cause inorganic salt residue, resulting in unqualified absorbance and content of the final product
CN103420979A uses low-level organic ketones and acetonitrile respectively, low-level organic ketones and organic alcohols to refine the crude esomeprazole sodium by means of two crystallizations. The number of times of refining is more, resulting in a lower yield of the final product, so the prior art process exists Large defects, basically unable to carry out industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Industrial production method of esomeprazole
  • Industrial production method of esomeprazole
  • Industrial production method of esomeprazole

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] 1. the preparation of formula II:

[0026]

[0027] Add 125Kg of dichloromethane, 11.0Kg (62.5mol) of 2-mercapto-5-methoxybenzimidazole, 13.8Kg of 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride (62.1mol), tetrabutylammonium bromide 400g, lower the temperature to 0-20°C, add dropwise sodium hydroxide solution (33.2kg) with a mass concentration of 20%, drop it within 30min, and heat up to 20-30°C Insulation reaction for 3-5 hours, HPLC confirms that the content of 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride of the raw material is less than 1.0%, let it stand for stratification, remove the lower organic layer, and saturated saline Wash, concentrate the solvent to a quarter of its volume, cool down in an ice-salt bath (step by step, takes 1hr) to 0°C, keep stirring for 2hrs, centrifuge to get a wet product, wash with 2.0Kg n-heptane, 50±5°C Blast drying (-0.09MPa) yielded 15.4±0.5Kg of white solid, omeprazole sulfide represented by formula I...

Embodiment 2

[0034] 1. the preparation of formula II:

[0035]

[0036] Add 125Kg of dichloromethane, 11.0Kg (62.5mol) of 2-mercapto-5-methoxybenzimidazole, 13.8Kg of 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride (62.1mol), benzyltriethylammonium chloride 400g, lower the temperature to 0-20°C, add dropwise sodium hydroxide solution (33.2kg) with a mass concentration of 20%, and finish dropping within 30min, then heat up to 20-30 Insulate and react at ℃ for 3 to 5 hours, HPLC confirms that the raw material is less than 1.0%, let stand and separate, remove the lower organic layer, wash with saturated saline, concentrate the solvent to a quarter of its volume, and cool down in a circulating ice-salt bath (cooling in stages, consumption 1hr) to 0°C, keep stirring for 2hrs, centrifuge to get wet product, sprinkle wash with 2.0Kg n-heptane, blow dry at 50±5°C (-0.09MPa), get 15.0±0.5Kg white solid, the yield is 83.0% . The melting point of the product is 118-120°C, the purity ...

Embodiment 3

[0041] 1. the preparation of formula II:

[0042]

[0043] Add 125Kg of dichloromethane, 11.0Kg (62.5mol) of 2-mercapto-5-methoxybenzimidazole, 13.8Kg of 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride (62.1mol), 400g of tetrabutylammonium chloride, lower the temperature to 0-20°C, add dropwise sodium hydroxide solution (33.2kg) with a mass concentration of 20%, and finish dropping within 30min, then heat up to 20-30°C Insulation reaction for 3-5 hours, HPLC confirms that the raw material is less than 1.0%, let stand and separate layers, remove the lower organic layer, wash with saturated saline, concentrate the solvent to a quarter of its volume, and cool down in an ice-salt bath (step by step cooling, time-consuming 1hr ) to 0°C, keep stirring for 2 hours, centrifuge to get wet product, sprinkle wash with 2.0Kg n-heptane, and blow dry at 50±5°C (-0.09MPa) to obtain 15.2±0.5Kg white solid with a yield of 84.0%. The melting point of the product is 118-120°C, th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an industrial production method of esomeprazole. According to the industrial production method, under the action of a phase transfer catalyst and strong alkali, omeprazole sulfur ether is prepared through condensation; through low-temperature asymmetric oxidation, the generation of nitric oxide and sulfone is reduced, an organic solution of esomeprazole (as shown in the formula III) is prepared, the organic solution can be directly fed into a sodium alcoholate solution, three steps namely asymmetric oxidation aftertreatment, salting and crystallization and refining are completed once, a finished esomeprazole product is prepared in multiple batches, the purity of the finished esomeprazole product is greater than 99.8%, the isomer of the finished esomeprazole product is less than 0.05%, the individual impurity of the finished esomeprazole product is less than 0.1%, and the medicine grade raw material medicine requirements are met. By adopting the preparation method, the step of extracting and purifying esomeprazole and esomeprazole sodium is canceled, the production period is shortened, the production cost is greatly reduced, the possibility that the sulfone impurity is increased in the production process is avoided, the preparation method is safe and reliable, simple and easy to operate, stable in salting and good in repeatability, and the product quality is greatly improved.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical production, in particular to an industrial production method of esomeprazole sodium. Background technique [0002] Esomeprazole sodium is a commonly used anti-ulcer drug, which was successfully developed by AstraZeneca in Sweden for the first time. It is the world's first isomer proton pump inhibitor (PPI) and is used for the treatment of peptic ulcer and gastroesophageal reflux disease. , (GERD), the drug of choice for acid-related diseases such as duodenal ulcer. Esomeprazole sodium reduces gastric acid secretion through a specific targeting mechanism. It is a specific inhibitor of proton pumps in parietal cells. Because of its definite curative effect, it has successfully replaced omeprazole and has become the first-line anti-ulcer heavyweight drug. [0003] [0004] CN102633776B and CN103601723A processes directly add excess sodium hydroxide solution to the reaction solution of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/12
CPCC07D401/12
Inventor 蒋维胡孟奇刘斐孙松
Owner 合肥远志医药科技开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products